The APROVEL 300 mg brand, founded in 2002 (France), from 2757 sister brands and 17477 competing brands. The APROVEL 300 mg brand is owned by SANOFI, a company listed in Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. APROVEL 300 mg belongs to the Drug Manufacturers business sector.
Share price and profitability of the share SANOFI (APROVEL 300 mg)
Buy SANOFI share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
SANOFI
(APROVEL 300 mg)
over 5 years*
EUR 102.23
Stock market history SANOFI (APROVEL 300 mg)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
